CD274 and neoplasm: This type of expression can be the result of inter alia PD-L1 gene amplification or aberrant activation of oncogenic signaling pathways and 2) “adaptive immune resistance” which refers to PD-L1 expression in response to inflammatory factors secreted in the TM during the immune response against a tumor (189).